Llwytho...
Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Gastroenterol Rep (Oxf) |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434590/ https://ncbi.nlm.nih.gov/pubmed/32843973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa018 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|